Outsourcing

Jun 19, 2018
By Pharmaceutical Technology Editors
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
Jun 14, 2018
By Pharmaceutical Technology Editors
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
Jun 13, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
Jun 07, 2018
By Pharmaceutical Technology Editors
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
Jun 06, 2018
By Pharmaceutical Technology Editors
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
Jun 02, 2018
Pharmaceutical Technology
By Pharmaceutical Technology Editors
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.
Jun 02, 2018
Pharmaceutical Technology
Open communication channels between all the parties involved is key when outsourcing analytical methods, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Jun 01, 2018
By Pharmaceutical Technology Editors
Rentschler Fill Solutions and Ultragenyx announce fill and finish agreement for the US commercial supply of Mepsevii.
Jun 01, 2018
By Pharmaceutical Technology Editors
FUJIFILM Diosynth Biotechnologies opens Cambridge, MA center to promote collaboration with biotech companies.
Jun 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
native1_300x100
lorem ipsum